| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
LYN |
LYN: Tyrosine-protein kinase Lyn |
18.430 |
Evidence |
|
| CD79A |
CD79A, IGA, MB1: B-cell antigen receptor complex-associated protein alpha-chain |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
18.430 |
Evidence |
|
| CD28 |
CD28: T-cell-specific surface glycoprotein CD28 precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
18.430 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
18.430 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
18.430 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
18.430 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
18.430 |
Evidence |
|
| CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
18.430 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
18.430 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
PPP2CB |
PPP2CB: Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform |
18.340 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
18.340 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
GRIA1 |
GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor |
18.340 |
Evidence |
|
| LMNA |
LMNA, LMN1: Lamin-A/C |
PLCB1 |
PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- |
18.340 |
Evidence |
|
| ACTN4 |
ACTN4: Alpha-actinin-4 |
GRIA1 |
GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor |
18.340 |
Evidence |
|
| PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
ALB |
ALB: Uncharacterized protein ALB |
18.320 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
18.320 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
18.320 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
PZP |
PZP: Pregnancy zone protein precursor |
18.320 |
Evidence |
|
| HIST1H2BO |
HIST1H2BO, H2BFH, H2BFN: Histone H2B type 1-O |
HIST1H2AC |
HIST1H2AC, H2AFL: Histone H2A type 1-C |
18.320 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
CSNK2A2 |
CSNK2A2, CK2A2: Casein kinase II subunit alpha' |
18.320 |
Evidence |
|
| ZNF638 |
ZNF638, NP220, ZFML: Zinc finger protein 638 |
EPRS |
EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: |
18.3 |
Evidence |
|
| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
PPID |
PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase |
18.3 |
Evidence |
|
| CDH7 |
CDH7, CDH7L1: Cadherin-7 precursor |
APC2 |
APC2, APCL: Adenomatous polyposis coli protein 2 |
18.230 |
Evidence |
|
| IL3 |
IL3: Interleukin-3 precursor |
IL3RA |
IL3RA, IL3R: Interleukin-3 receptor alpha chain precursor |
18.230 |
Evidence |
O
|
| F9 |
F9: Coagulation factor IX precursor |
NOG |
NOG: Noggin precursor |
18.210 |
Evidence |
|